APP下载

药食同源利水方治疗原发性肝癌腹水的临床研究

2020-06-11郝爱凤

中外医疗 2020年9期

郝爱凤

[摘要] 目的 研究藥食同源利水方治疗原发性肝癌腹水的临床治疗效果,为临床治疗工作的开展提供必要保障。方法随机将方便选取2018年5月—2019年5月该院40例原发性肝癌腹水患者分为实验组(20例,应用中西医结合治疗)、对照组(20例,应用西医常规治疗)。对比两组患者腹水治疗效果、中医症状积分。 结果 实验组临床治疗总有效率为95%(19/20),高于对照组(65%,13/20),差异有统计学意义(χ2=5.625,P=0.018 <0.05);治疗前,实验组各项中医症状积分与对照组相比,差异无统计学意义(P>0.05)。治疗后,实验组恶心呕吐积分为(0.31±0.29)分、发热乏力积分为(0.41±0.32)分、腹肿胀满积分为(0.61±0.47)分、腹胀膨隆积分为(0.87±0.35)分,均比对照组低,差异有统计学意义(t=9.485、5.640、3.333、7.934,P=0.000、0.000、0.002、0.000 0.05)。结论 临床治疗原发性肝癌腹水,应用自拟的药食同源利水方,疗效确切,无毒副作用,可有效提高患者的生活质量水平,减少中医症状积分,无不良反应发生。

[关键词] 药食同源利水方;原发性肝癌腹水;临床治疗效果

[中图分类号] R735.7          [文献标识码] A          [文章编号] 1674-0742(2020)03(c)-0171-03

Clinical Study on the Treatment of Ascites of Primary Liver Cancer with Homologous Drug-Food Lishui Prescription

HAO Ai-feng

Department of Oncology, Jingdong Zhongmei Hospital, Langfang, Hebei Province, 065000 China;

Department of Internal Medicine, Siping Shennong Hospital, Siping, Jilin Province, 136000 China

[Abstract] Objective To study the clinical therapeutic effect of the medicine and food homologous Lishui prescription in the treatment of ascites of primary liver cancer, and provide necessary guarantee for the development of clinical treatment. Methods From May 2018 to May 2019, 40 patients with primary liver cancer ascites were convenient selection randomly divided into experimental group (20 cases, combined with traditional Chinese and western medicine) and control group (20 cases, treated with western medicine). The therapeutic effect of ascites and TCM symptom scores were compared between the two groups. Results The total effective rate of clinical treatment in the experimental group was 95% (19/20), which was much higher than that in the control group (65%, 13/20). The difference was statistically significant(χ2=5.625,P=0.018<0.05). Before treatment, the scores of TCM symptoms in the experimental group were not significantly different from those in the control group(P>0.05). After treatment, the scores of nausea and vomiting in the experimental group were (0.31±0.29)points, the score of fever fatigue was (0.41±0.32)points, the score of abdominal swelling was (0.61±0.47)points, and the score of bloating was (0.87±0.35)points. They were lower than the control group. There was statistically significant difference between the groups (t=9.485,5.640,3.333,7.934,P=0.000,0.000,0.002,0.000 <0.05). Conclusion The clinical treatment of ascites of primary liver cancer, the application of self-made medicine and food homologous water side, the curative effect is exact, no toxic and side effects, can effectively improve the quality of life of patients, reduce the scores of TCM symptoms, no adverse reactions occur.

[Key words] Medicine and food; Primary liver cancer ascites; Clinical therapeutic effect

原发性肝癌为恶性肿瘤常见类型,起病隐匿且发展迅速,很多患者在就诊时已经处于中晚期,错过最佳治疗时机,仅能够接受保守治疗[1]。以肝区疼痛明显、神疲乏力以及食少纳差为主要临床表现,甚至会出现腹水、黄疸、出血以及昏迷等症状,最常见的就是癌性腹水[2]。原发性肝癌腹水主要是受病变影响而损伤肝功能,血浆白蛋白合成减少,降低了血浆胶体渗透压或者是门静脉压力增加,引发细胞内外水液代谢失衡,细胞内水液渗透至腹壁,最终出现腹水[3]。一旦腹水出现提示治疗难度大、生活质量差、预后凶险,故对腹水的治疗是缓解肝癌患者病情的重要环节。……

登录APP查看全文